Background Long-acting injectable (LAI) human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP) is reportedly efficacious, although full trial results have not been …
Background Long-acting injectable HIV pre-exposure prophylaxis (LAI-PrEP) is reportedly efficacious, although full trial results have not been published. We used a dynamic network …
Introduction: The science presented at the 21st International AIDS Conference in Durban, South Africa, in July 2016, addressed the state of the field across basic, clinical, prevention …
KM Maloney, RA Driggers, S Sarkar, E Anderson… - researchgate.net
Objective: To assess the population impact of long-acting injectable pre-exposure prophylaxis (LAI-PrEP) when available concurrently with daily oral (DO) PrEP among men …